Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 111

Similar articles for PubMed (Select 21334367)

1.

Attention-modulating effects of cognitive enhancers.

Levin ED, Bushnell PJ, Rezvani AH.

Pharmacol Biochem Behav. 2011 Aug;99(2):146-54. doi: 10.1016/j.pbb.2011.02.008. Epub 2011 Feb 18. Review.

2.

Attenuation of pharmacologically-induced attentional impairment by methylphenidate in rats.

Rezvani AH, Kholdebarin E, Cauley MC, Dawson E, Levin ED.

Pharmacol Biochem Behav. 2009 Mar;92(1):141-6. doi: 10.1016/j.pbb.2008.11.005. Epub 2008 Nov 17.

PMID:
19041337
3.

Effects of chronic sazetidine-A, a selective α4β2 neuronal nicotinic acetylcholine receptors desensitizing agent on pharmacologically-induced impaired attention in rats.

Rezvani AH, Cauley M, Xiao Y, Kellar KJ, Levin ED.

Psychopharmacology (Berl). 2013 Mar;226(1):35-43. doi: 10.1007/s00213-012-2895-6. Epub 2012 Oct 26.

PMID:
23100170
4.

Improvement of attentional function with antagonism of nicotinic receptors in female rats.

Levin ED, Cauley M, Rezvani AH.

Eur J Pharmacol. 2013 Feb 28;702(1-3):269-74. doi: 10.1016/j.ejphar.2013.01.056. Epub 2013 Feb 8.

5.

Effects of AZD3480, a neuronal nicotinic acetylcholine receptor agonist, and donepezil on dizocilpine-induced attentional impairment in rats.

Rezvani AH, Cauley MC, Johnson EC, Gatto GJ, Levin ED.

Psychopharmacology (Berl). 2012 Oct;223(3):251-8. doi: 10.1007/s00213-012-2712-2. Epub 2012 Apr 20.

PMID:
22526540
7.

Sazetidine-A, a selective α4β2 nicotinic acetylcholine receptor ligand: effects on dizocilpine and scopolamine-induced attentional impairments in female Sprague-Dawley rats.

Rezvani AH, Cauley M, Sexton H, Xiao Y, Brown ML, Paige MA, McDowell BE, Kellar KJ, Levin ED.

Psychopharmacology (Berl). 2011 Jun;215(4):621-30. doi: 10.1007/s00213-010-2161-8. Epub 2011 Jan 28.

PMID:
21274704
8.

Chronic nicotine and dizocilpine effects on nicotinic and NMDA glutamatergic receptor regulation: interactions with clozapine actions and attentional performance in rats.

Rezvani AH, Tizabi Y, Getachew B, Hauser SR, Caldwell DP, Hunter C, Levin ED.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 May 15;32(4):1030-40. doi: 10.1016/j.pnpbp.2008.01.018. Epub 2008 Feb 12.

PMID:
18343006
9.
10.

Nicotine and clozapine effects on attentional performance impaired by the NMDA antagonist dizocilpine in female rats.

Rezvani AH, Kholdebarin E, Dawson E, Levin ED.

Int J Neuropsychopharmacol. 2008 Feb;11(1):63-70. Epub 2007 Feb 13.

PMID:
17295931
11.

Behavioral and pharmacological studies on the validation of a new animal model for attention deficit hyperactivity disorder.

Puumala T, Ruotsalainen S, Jäkälä P, Koivisto E, Riekkinen P Jr, Sirviö J.

Neurobiol Learn Mem. 1996 Sep;66(2):198-211.

PMID:
8946412
12.

Nicotinic-antipsychotic drug interactions and cognitive function.

Levin ED, Rezvani AH.

EXS. 2006;98:185-205. Review.

PMID:
17019889
13.

Effects of methylphenidate on attentional set-shifting in a genetic model of attention-deficit/hyperactivity disorder.

Cao AH, Yu L, Wang YW, Wang JM, Yang LJ, Lei GF.

Behav Brain Funct. 2012 Feb 28;8(1):10. doi: 10.1186/1744-9081-8-10.

14.

Cognitive effects of neonatal hippocampal lesions in a rat model of schizophrenia.

Chambers RA, Moore J, McEvoy JP, Levin ED.

Neuropsychopharmacology. 1996 Dec;15(6):587-94.

15.

Development of nicotinic drug therapy for cognitive disorders.

Levin ED, Rezvani AH.

Eur J Pharmacol. 2000 Mar 30;393(1-3):141-6.

PMID:
10771007
16.

Nicotinic agonist-induced improvement of vigilance in mice in the 5-choice continuous performance test.

Young JW, Meves JM, Geyer MA.

Behav Brain Res. 2013 Mar 1;240:119-33. doi: 10.1016/j.bbr.2012.11.028. Epub 2012 Nov 29.

17.

Spontaneously hypertensive rats do not predict symptoms of attention-deficit hyperactivity disorder.

van den Bergh FS, Bloemarts E, Chan JS, Groenink L, Olivier B, Oosting RS.

Pharmacol Biochem Behav. 2006 Mar;83(3):380-90. Epub 2006 Mar 6.

PMID:
16580713
18.

Effects of nicotine and mecamylamine on choice accuracy in an operant visual signal detection task in female rats.

Rezvani AH, Bushnell PJ, Levin ED.

Psychopharmacology (Berl). 2002 Dec;164(4):369-75. Epub 2002 Sep 20.

PMID:
12457266
19.

Putative cognitive enhancers in preclinical models related to schizophrenia: the search for an elusive target.

Barak S, Weiner I.

Pharmacol Biochem Behav. 2011 Aug;99(2):164-89. doi: 10.1016/j.pbb.2011.03.011. Epub 2011 Mar 21. Review.

PMID:
21420999
20.

Chronic caffeine treatment during prepubertal period confers long-term cognitive benefits in adult spontaneously hypertensive rats (SHR), an animal model of attention deficit hyperactivity disorder (ADHD).

Pires VA, Pamplona FA, Pandolfo P, Prediger RD, Takahashi RN.

Behav Brain Res. 2010 Dec 20;215(1):39-44. doi: 10.1016/j.bbr.2010.06.022. Epub 2010 Jun 25.

PMID:
20600342
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk